Funded by SmithKline Beecham, study 329 was an eight-week, double-blind, randomized clinical trial conducted in 12 university or hospital psychiatric departments in the United States and Canada between 1994 and 1997 [REF].
The results showed that, according to the eight outcomes Keller had first specified, paroxetine was no more effective than placebo.